Timothy Chlon.

Timothy M. Chlon, PhD


  • Member, Division of Experimental Hematology and Cancer
  • Instructor, UC Department of Pediatrics

About

Publications

Heterozygous Mutations in DDX41 Cause Erythroid Progenitor Cell Defects. Chlon, TM; Stepanchick, E; Sulentic, A; Hueneman, K; Starczynowski, D. Blood. 2021; 138:148-148.

Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Chlon, TM; Stepanchick, E; Hershberger, CE; Daniels, NJ; Hueneman, KM; Kuenzi Davis, A; Choi, K; Zheng, Y; Gurnari, C; Haferlach, T; et al. Cell Stem Cell. 2021; 28:1966-1981.e6.

The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia. Niederkorn, M; Ishikawa, C; M. Hueneman, K; Bartram, J; Stepanchick, E; R. Bennett, J; E. Culver-Cochran, A; Bolanos, LC; Uible, E; Choi, K; et al. Leukemia. 2021.

Chronic immune response dysregulation in MDS pathogenesis. Barreyro, L; Chlon, TM; Starczynowski, DT. Blood. 2018; 132:1553-1560.